ApprovalTrail

Drug · DIN 02386054

APO-ELETRIPTAN

Authorized, but not sold for a year or more

Authorized, but the company reports it has not been sold in Canada for at least 12 months.

Status Dormant since February 6, 2022; first marketed September 12, 2013.
Drug Identification Number (DIN)
02386054
Company (DIN owner)
Apotex Inc.Toronto, Ontario, Canada
Schedule
Prescription
Dosage form
Tablet
Route
Oral
Therapeutic class (ATC)
Eletriptan N02CC06
Class
Human
Record last updated
March 22, 2025

Active ingredients

As listed in the Drug Product Database.

IngredientStrengthPer
ELETRIPTAN (ELETRIPTAN HYDROBROMIDE)20 MG

Notices of Compliance

Health Canada approvals that name this DIN.

Other DINs named APO-ELETRIPTAN